ESTRO Multidisciplinary Management of Breast Cancer 2017

Less local treatment: discussion

Side effects

Continuation of tamoxifen treatment after

adjuvant tamoxifen for 1–4 years may provide

Japanese breast cancer patients with better

HRQOL than by switching to anastrozole.

Ohsumi S, et al. Breast Cancer Res Treat. 2011;127:143–152